Intelligence Platform
Patents
Browse 2,147 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 6749856
Mucosal cytotoxic T lymphocyte responses
expired patentUS 6747055
Water-soluble drugs and methods for their production
expired patentUS 6743626
Artificial salivary gland
expired patentUS 6743577
Methods of using cyanovirins to inhibit viral infection
expired patentUS 6737251
Nucleotide and deduced amino acid sequences of tumor gene Int6
expired patentUS 6737511
Receptor-mediated uptake of an extracellular BCL-xL fusion protein inhibits apoptosis
expired patentUS 6734014
Methods and compositions for transforming dendritic cells and activating T cells
expired patentUS 6719978
Virus-like particles for the induction of autoantibodies
expired patentUS 6713081
Ocular therapeutic agent delivery devices and methods for making and using such devices
expired patentUS 6713066
Production of attenuated respiratory syncytial virus vaccines involving modification of M2
expired patentUS 6709842
DNA encoding a growth factor specific for epithelial cells
expired patentUS 6710166
41 kDa Cryptosporidium parvum oocyst wall protein
expired patentUS 6706873
Recombinant proteins of a pakistani strain of hepatitis E and their use in diagnostic meth
expired patentUS 6699835
Formulation of boronic acid compounds
expired patentUS 6699842
Dominant negative deletion mutants of C-jun and their use in the prevention and treatment
expired patentUS 6696242
Recombinant proteins of a Pakistani strain of hepatitis E and their use in diagnostic meth
expired patentUS 6696064
Methods of protecting vasculature from damage by diphtheria toxin-and pseudomonas toxin-ba
expired patentUS 6696562
Avian astrovirus
expired patentUS 6689560
Raf protein kinase therapeutics
expired patentUS 6689383
Chromium-histidine complexes as nutrient supplements
expired patentUS 6689367
Production of attenuated chimeric respiratory syncytial virus vaccines from cloned nucleot
expired patentUS 6685949
Lipooligosaccharide based vaccine for prevention of moraxella (branhamella)catarrhalis inf
expired patentUS 6685948
Replication-defective dengue viruses that are replication-defective in mosquitoes for use
expired patentUS 6685944
Modified HCV peptide vaccines
expired